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Histone mediates glomerular deposition of small size DNA
anti-DNA complex
TETSUO MoRIoIc&,' RAINER W0ITAs, Y0sHIHIDE FuJIGAKI, STEPHAN R. BATSFORD,
and ARNOLD VOGT
Inst it ut für Medizinisehe Mikrobiologie und Hygiene, Abteilung Immunologie, Freiburg, Germany
Histone mediates glomerular deposition of small size DNA-anti-DNA
complex. Histone can mediate the binding of free DNA to the glomer-
ular capillary wall. We tested whether histone could mediate the
deposition of preformed DNA-anti-DNA immune complex (IC). IC
were generated using monoclonal anti-DNA Ab and excess of small size
'251-DNA; after further digestion with DNase the IC, containing 5 sg
DNA (now 20 to 60 bp), was injected into the left kidney of rats. When
given alone, only about 0.2% of the IC bound in glomeruli. Prior
injection of 200 g of core histones (H2A,H2B,H3,H4) resulted in high
glomerular binding of the IC; 18.1% of the injected dose (measured as
'251-DNA) was bound at 15 minutes. Mouse immunoglobulin, represent-
ing the IC, could be seen in a capillary pattern. C3 was also present in
a similar pattern, showing that complement had been activated. Dis-
crete electron-dense deposits were seen in a subendothelial and subep-
ithelial localization at 15 minutes. Although about 1 ig of DNA was
deposited in the glomeruli, it could not be detected by indirect iinmu-
nofluorescence or intercalating dyes. These studies provide direct
evidence that histones can mediate the binding of particular circulating
DNA-anti-DNA immune complexes to the glomerular capillary wall in
vivo. If small size DNA fragments (<100 bp) are involved in lupus
nephritis, our results provide a possible explanation for the frequent
failure to detect DNA deposits in renal biopsies from SLE patients.
Lupus nephntis is a frequent and prognostically unfavorable
organ manifestation of systemic lupus erythematosus (SLE).
The granular pattern of glomerular deposits of autologous
immunoglobulin and complement point to an immune complex
disease [1]. Elevated levels of circulating anti-ds-DNA antibody
in SLE were often followed by active manifestation of renal
disease [2, 3]. Anti-DNA antibodies have been shown to be
present in renal and glomerular eluates obtained from SLE
patients and lupus mice [4-6]. From these data it was deduced
that DNA-anti-DNA immune complexes play a major role in the
pathogenesis of tissue injury in SLE, although successful de-
tection of DNA itself remained the exception [7—9].
It has been proposed that histones may play a major role in
the binding of DNA to the GBM. Histones have a high affinity
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for the rat GBM and deposited histones could mediate the
subsequent binding of polydisperse DNA fragments to the
GBM in vivo [10, 11]. Histones have also been shown to be
present in glomerular immune deposits of lupus mice [12] and in
kidney biopsies of SLE patients [13].
DNA could bind to the planted histone either in free form or
when complexed with antibody. Large DNA fragments, in free
or complexed form, were shown to be rapidly cleared from the
circulation by the liver [14, 15]. Small DNA-anti-DNA com-
plexes could circulate longer [14, 15] and this would increase
their chance of depositing in the GBM. The present, quantita-
tive study provides direct evidence that histone can effectively
mediate glomerular binding of small DNA fragments previously
complexed to anti-DNA antibody.
Methods
Animals
Male Wistar rats (150 g) (Zentraltierzuchterei, Hannover,
Germany) were used throughout. All injections and surgical
procedures were carried out under ether narcosis.
Histone preparation
Histones were prepared from chicken erythrocytes. Hepa-
rinized chicken blood was centrifuged at 3,000 g for 10 minutes,
the plasma and buffy coat were removed. The erythrocytes
were washed twice with isotonic saline solution and frozen at
—70°C. Erythrocytes were thawed at 37°C with an equal volume
of 0.15 M NaC1, containing 0.015 M Na-citrate, pH 7.2 (saline!
citrate) and centrifuged at 3,000 g for 10 minutes. The nuclear
pellet was resuspended in 0.25% Nonidet P-40 in saline/citrate,
repelleted and washed with saline/citrate. The natural histone
octamer complex was isolated essentially according to the
procedure of Ruiz-Carillo and Jorcano [16]. Washed nuclei
were extracted with 0.75 M NaCI, 10 mvt Tris/HC1, pH 7.4,
containing 0.5 /Lg/ml of the protease inhibitor leupeptin, for one
hour to remove Hi and H5. The residual nucleohistone was
sedimented at 46,000 rpm in a 60 Ti rotor (Beckman) for 16
hours. The resulting pellet was homogenised in 2 M NaCl, 10
mM Tris/HC1, 0.5 g/ml leupeptin, pH 7.4. Extraction was
allowed to proceed for one hour and DNA was pelleted by
centrifugation as before. The supernatant, containing core
histones, was concentrated to 12 mg/mi using ultrafiltration with
an Amicon YM-lO membrane. The natural octamer was isolated
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Fig. 1. Isolation of histone octamers. Gel
exclusion chromatography on Sephadex G-100
column (2.5 X 90 cm) of the histone
complexes, free of DNA. SDS-PAGE gel of
fraction A,B,C and total histones (T) is
shown. Peak A contains the octamer.
from this solution via size exclusion chromatography on a
Sephadex G-l00 column (Pharmacia) (2.5 x 90 cm) in 2 M NaCI,
10 mM Tris/HC1, 0.5 tg/ml leupeptin, flow rate was 10 ml/hr and
effluent was monitored at 280 nm. Histone octamers (in 2 M
NaCl) were diluted with an equal volume of glycerol and stored
at —20°C; before use in animal experiments they were dialyzed
against PBS.
DNA
Highly polymenzed calf thymus dsDNA (Sigma Chemical
Co., D 1501) was dissolved in PBS and deproteinized by
repeated phenol-chloroform extraction as described by Sam-
brook, Fritsch and Maniatis [17], followed by dialysis against
0.1 M ammonium acetate/0.04 M acetic acid (pH 5.0). An aliquot
of 50 g of DNA was radiolabeled at a concentration of 0.4
mglml with 1251, by the method of Commerford [18]. After
extensive dialysis against PBS, radiolabeled DNA was added to
non-labeled DNA and digested with DNase I type IV (5 pg/mg
DNA) (Sigma, D 5025) for five minutes at 25°C in the presence
of 5 m MnSO4, digestion was stopped by adding Na-EDTA.
The DNA was deproteinized again and dialyzed against PBS.
Analysis by PAGE revealed a size of between 200 and 1000 bp.
Monoclonal antibody
Hybridoma cell lines producing anti-DNA Ab were obtained
by the fusion of spleen cells from female NZBIW Ft mice (5 to
8 months old) with Ag 8 myeloma cells. Screening was done by
two methods: indirect immunofluorescence on kidney sections
from rat kidneys perfused with polyethyleneimine followed by
ds-DNA [19], and by enzyme-linked immunosorbent assay
(ELISA) by the method of Faaber et al [20]. The antibody
chosen had an IgG2a isotype and reacted with both ss- and
ds-DNA. The isoelectric point of this antibody was 6.3 (deter-
mined by isoelectric focusing in a flat bed gel). Hybridoma cells
were cultured in PFHMII medium (Gibco). Monoclonal anti-
body was initially enriched by 50% ammonium sulfate precipi-
tation of culture supernatant. It is known that crude monoclonal
anti-DNA antibody from hybridoma cultures may be corn-
plexed to histone-DNA aggregates [21]. To isolate the antibody
further purification was done under dissociating conditions as
follows: the MoAb fraction was dialyzed against 3 M NaCl, 1.5
M glycine-NaOH, pH 8.9 (binding buffer) and applied to a
protein-A column (Pharmacia, Uppsala, Sweden) equilibrated
in binding buffer. Bound immunoglobulins were eluted with 0.1
M glycine-citrate pH 2.8 and the eluate was dialyzed against
PBS containing 0.01% NaN3 and stored at 4°C.
Formation of immune complex
'251..DNA and monoclonal anti-DNA antibody were incu-
bated at 37°C for four hours in 10 molar DNA excess to form IC.
IC was then subjected to digestion with DNAse l/lY (Sigma, D
5025) at 10 pg/mg DNA, in 10 m MgC12 at 37°C for 30 minutes.
IC was precipitated with an equal volume of saturated ammo-
nium sulfate, free DNA fragments remaining in suspension, the
precipitated IC was resuspended and dialyzed against PBS. The
quantity of DNA in the IC could be estimated from the
radioactivity and the protein content (antibody) from the ex-
tinction at 280 nm.
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Table 1. Histone-mediated glomerular binding and organ uptake of
'251-DNA-anti-DNA immune complexes
Organ Histone + IC PBS + IC
Left kidney 25.9 3.9 2.6 0.6
Right kidney 1.7 0.2 1.6 0.1
Liver 20.6 0.2 31.5 4.8
Spleen 0.8 0.2 0.6 0.1
Lung 1.9 0.4 0.9 0.1
Heart 0.3 0.2 0.3 0.1
Blood (1 ml) 1.9 0.6 2.2 0.2
Isolated glomeruli
from left kidney 18.1 2.3 0,2 0.1
Five micrograms (as DNA) of immune complex were injected subse-
quent to 200 of core histones (H2A, H2B, H3, H4) via the aorta into
left kidney of rats. In control rats, PBS was given instead of histones
prior to IC injection. At 15 minutes the organs were removed and
radioactivity was counted.
Data are presented as mean SD (% of injection dose).
Electrophoresis
SDS-PAGE was carried out as described by Laemmli [221, a
15% running gel and a 4% stacking gel was used. Gels were
stained with Coomassie blue R250.
Isoelectrofocusing was performed in polyacrylamide gels (C
5.5%, T 2.7%) with 6% ampholyte (pH range 3.5 to 10). Gels
were stained with Coomassie blue R250.
Immunofluorescence
Renal tissue was snap frozen in cold isopentane; 5 jm
cryostat sections were fixed in acetone. For detection of histone
H3, sections were incubated with a rabbit anti-histone H3 sera
[101, followed by FITC-labeled mouse anti-rabbit IgG (Dianova,
Hamburg, Germany), staining for mouse IgG, rat IgG and rat
C3 was also performed.
Detection of DNA
Immunofluorescent staining was performed using a human
serum with a high titer of anti-dsDNA antibody (Fan assay>
96%; crithidia luciliae kinetoplast IF titer >1:320) which did not
react with histones in Western blot. Frozen kidney sections
were incubated first with the serum diluted 1:50 followed by
FITC-labeled rabbit anti-human IgG.
Staining for dsDNA was also performed with the intercalating
dyes DAPI and acrydine orange (Polysciences, Germany).
Acetone fixed, frozen sections were incubated with solutions of
the dye (final concentrations: DAPI 10 jxg/ml in 0.1 M NaCl,
0.01 M Tris-HC1, 0.01 M Na-EDTA, pH 7.3, acrydine orange 40
tg/ml in PBS/0.0l M Na-EDTA pH 7.3) for 10 seconds, washed
briefly in PBS and viewed under the fluorescence microscope.
Two controls were employed. These were positive nuclear
fluorescence of cells in the section and staining of large size
DNA fragments previously planted in rat glomeruli in high
quantities [10, 23].
Experimental protocol
Histone octamers and immune complexes were injected via
the aorta into the left kidney of rats. The procedure was as
follows: first 0.2 ml of PBS were injected to remove blood,
followed by 200 jxg core histones (0.4 ml; N = 4) or 0.4 ml PBS
(control; N = 4); the kidney was flushed with 0.1 ml of PBS
Table 2. Disappearance of 1251-DNA from left kidney and glomeruli
after intraaortal injection
Time after
injection
Histone + IC PBS + IC
Kidney
Isolated
glomeruli Kidney
Isolated
glomeruli
15 mm
1 hour
4 hours
25.9 3.9
18.1 7.0
2.8 0.3
18.1 2,3
12.0 5.3
1.3 0.3
2.7 0.6
2.5 0.5
1.0 0.2
0.2 0.1
<0.1
<0.1
Data are mean of 4 rats SD (% of injection dose).
Table 3. Glomerular immune histology in rats given DNA-anti-DNA
Ab immune complexes
Time
Histone
Histone + PBS +
IC IC
Mous
Histone
IC
e IgG
+ PBS +
IC
Rat C3
Histone + PBS +
IC IC
15mm +++a + ++
ihour +++ — + — ++ —
4hours ++ — — + —
a Intensity of fluorescence (mean of 4 rats)
prior to injection of 5 jsg (measured as DNA) of IC (0.4 ml),
followed by 0.2 ml PBS for removal of unbound IC; then normal
blood flow was re-established. When kinetic studies were
performed, perfusion procedures were done as above, then the
abdominal wall was closed and the skin was joined with clamps.
Fifteen minutes, one hour and four hours later 1 ml blood was
taken from the right jugular vein and both kidneys were
perfused with 2 ml of PBS via the aorta after clamping the aorta
above the arteries and severing both renal veins. Both kidneys
were removed, weighed, the total radioactivity was counted,
then a part of each kidney was taken for immunofluorescence.
The glomeruli were isolated from the remainder of the left
kidney and the radioactivity was measured. The number of
glomeruli isolated was estimated by direct counting of an
aliquot. It was assumed that a single kidney contained 38,000
glomeruli [24]. In addition, at 15 minutes only liver, spleen, lung
and heart were removed, and the radioactivity was counted. As
a further control histone perfusion was followed by injection of
anti-DNA MoAb, treated as IC without adding DNA (see
above), in place of complete IC (in this latter case only
immunofluorescence studies were performed). Electron micros-
copy was performed on renal tissue from rats given histone
alone (one rat) or histone followed by IC (two rats) 15 minutes
after injection. Renal tissue was fixed in 2% glutaraldehyde and
prepared for conventional electron microscopy, epon-embed-
ded ultrathin sections were stained with uranyl acetate and lead
citrate and viewed under an electron microscope (Zeiss, EM
bA).
Results
Core histones
Native histone octamers containing H2A, H2B, H3 and H4
were isolated by the procedure described. Electrophoretic
analysis revealed no contamination with histone Hl/H5 or with
other proteins and no signs of proteolysis were apparent (Fig.
1). The isoelectric point of this complex exceeded 9.5, as
measured by IEF.
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Fig. 2. Immunofluorescence micrographs.
Two hundred micrograms of core histones
were perfused via the aorta into the left renal
artery followed by DNA-anti-DNA IC. Rat
kidneys were examined 15 minutes after
injection. A. Detection of histone H3 by
indirect immunofluorescence (first antibody;
rabbit-anti-H3 antisera, second antibody;
FITC-anti-rabbit IgG). Histones are deposited
in a linear to granular fashion along the GBM
and the peritubular capillaries (original
magnification x400). B. Detection of mouse
IgG by direct immunofluorescence. FITC-anti-
mouse IgG. Mouse IgG is deposited in a
granular pattern along the glomerular capillary
loops (original magnification x400). C.
Detection of rat C3 by direct
immunofluorescence. FITC-anti-rat C3. Rat
complement is seen in a granular pattern
mainly in the glomerular capillary ioops
(Original magnification x400).
Characterization of DNA and IC Binding of IC in kidney and glomeruli
The size of DNA fragments that were incorporated into IC Five micrograms of IC (as DNA) were injected into the left
was analyzed by PAGE, these lay between 20 to 60 bp (13 to 38 kidney of rats subsequent to injection of core histones or PBS.
kD). The ratio of DNA to anti-DNA antibody protein was The initial experiments were performed at 15 minutes, the organ
estimated to be approximately 1:1. distribution is shown in Table 1. A total of 25.9% of IC bound
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Fig. 2. Continued
to the left kidney following core histone injection, but when the
histone injection was omitted only 2.6% of IC bound. In
glomeruli isolated from the same kidneys, 18.1% of the injected
dose was deposited after histone perfusion, but only 0.2% was
found without prior injection of histones (Table 1). At one hour,
12.0% of the IC remained in the glomeruli, falling to 1.3% at
four hours (Table 2). As expected the highest extrarenal local-
ization was seen in the liver (20.6%, Table 1). This increased to
31.5% when histone was omitted from the perfusion schedule.
Uptakes in other organs were low (Table 1).
Immunofluorescence
The fluorescence findings are summarized in Table 3. Fifteen
minutes after renal perfusion histones were seen along both the
capillary and peritubular capillary walls (Fig. 2A). The IC (the
antibody component) was seen mainly along the glomerular
capillary wall (Fig. 2B) together with rat complement (Fig. 2C).
When monoclonal anti-DNA antibody alone followed histone
perfusion, no deposition of mouse IgG or rat C3 could be seen
in the glomeruli, whereas the staining for histone was un-
changed. One hour after renal perfusion, histone was only seen
in the glomeruli, and the staining pattern and intensity of
staining for mouse IgG (IC) and rat C3 were the same as at 15
minutes after renal perfusion. Four hours after renal perfusion
the deposition of histone was more granular in nature and the
intensity had decreased. Mouse IgG (IC) now showed a focal
distribution in the glomeruli, rat complement was still clearly
seen and the pattern was the same as at 15 minutes.
Electron microscopy
In rats perfused only with histones, small, indistinct deposits
in both the lamina rara interna and externa were seen at 15
minutes. These probably correspond to the histone fixed to
glomerular anionic sites (Fig. 3A). Rats given histone followed
by IC showed regular, discrete, small electron-dense deposits in
the lamina rara interna and less regularly in the lamina rara
externa at 15 minutes (Fig. 3B).
Detection of DNA
The experiments with '251-labeled dsDNA showed that about
1 g of DNA was deposited in the glomeruli of the perfused
kidney at 15 minutes. Attempts to visualize dsDNA by indirect
IF and with the intercalating dyes DAPI and acrydine orange
were negative, both methods produced strong positive staining
of cell nuclei and DNA deposits produced in rat kidneys as
described in the Methods.
Discussion
In previous reports it was shown that planted histone can
mediate the subsequent, sequential binding of DNA fragments
and anti-DNA antibody in rat glomeruli [10, 11]. During the
natural course of SLE the appearance of anti-dsDNA antibody
usually preceeds glomerulonephritis and it appears more likely
that DNA reaches the kidney in complexed form. The following
mechanisms can be postulated: (1) histone first affixes to the
GBM and then mediates the binding of preformed DNA-anti-
DNA complexes to this structure, (2) circulating, preformed
histone-DNA-anti-DNA complexes bind directly to the GBM
via their histone component. In respect of the latter proposal,
up to now we have been unable to produce soluble, stable
complexes of histone, DNA and anti-DNA antibody. We there-
fore focused on the first mechanism and showed that core
histone could mediate the binding of preformed DNA-anti-DNA
immune complexes. There was a tenfold increase in binding to
the kidney and nearly a 100-fold increase in glomerular binding
of this IC following prior administration of histone.
t - -
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Fig. 3. Electron micrograph of a GBM section. Fifteen minutes after
renal perfusion of histones alone (A) or histones followed by immune
complexes (B). (A) Small, indistinct deposits can be seen both in lamina
rara interna and externa (arrows) (x 50,000). (B) Discrete electron-
dense deposits are regularly seen in the lamina rara interna (arrows) and
less regularly in the lamina rara externa (arrow heads) (x50,000).
Small complexes were selected for use in our study, since
they may persist in the blood for long periods [14, 15]. In
addition it has been reported that circulating IC in the sera of a
patient with SLE contained small dsDNA fragments of 30 to 40
bp [25]. Free DNA is readily cleaved by DNase in the circula-
tion, but some protection is afforded by antibody and only
exposed DNA is removed, this would result in small size
complexes [15]. Large DNA-anti-DNA complexes, on the other
hand, are very rapidly cleared from the circulation through the
liver [15]. The deposited IC activated the complement system,
as evidenced by C3 deposition. This fits with results from in
vitro experiments reported by Horgan and Emlen [26], who
showed that similar DNA-anti-DNA complexes of small size
could fix complement in vitro. Anti-DNA antibody was only
deposited when administered in complexed form, antibody
alone did not bind to planted histone. We assume that the
DNA-anti-DNA IC entered the GBM in complexed form,
although this could not be directly tested. Caulin-Glaser, Gallo
and Lamm [27] demonstrated that intact (covalently linked) IC
were able to deposit in the GBM, thus dissociation of IC is
certainly not a prerequisite for successful binding. The presence
of the IC was revealed by positive IF staining for the antibody
component and by radioisotopic detection of the stably labeled
DNA, about I pg of DNA was found in the glomeruli from one
kidney. Attempts to detect DNA using intercalating dyes as
well as indirect immunofluorescence did not produce positive
staining. In the case of indirect immunofluorescence the small
DNA fragments may have been masked by antibody, with
intercalating dyes the DNA fragments bound may have been
too small. We know from a previous study [23] that both
techniques are sensitive enough to detect less than 1 g of
polydisperse DNA (200 to 1,000 bp) in the glomeruli of one
kidney. If DNA fragments of similar small size (20 to 60 bp) are
involved in lupus nephritis in humans and in lupus prone mice,
this would help explain why reports of successful detection of
DNA in glomerular deposits are the exception rather than the
rule [7—9].
In this study we have shown that when histones are deposited
in the GBM, they can mediate the binding of DNA-anti-DNA
Ab complexes to the GBM. Electron microscopy showed the
deposits to be discrete and mainly in the subendothelial area at
15 minutes. The IC were cleared rapidly from the glomerulus,
which would limit formation of large electron dense deposits. A
single injection of small quantities of IC is not a true reflection
of events occurring in spontaneous lupus disease, a continuous
supply of histone and IC may be required for producing large
electron dense deposits. In addition other antigen-antibody
systems, such as rheumatoid factor or complexes of other
charged nuclear antigens and their respective antibodies may be
required.
Further support for involvement of histones in lupus nephritis
is provided by some recent studies where glomerular deposits
of histones were reported in lupus prone mice [12] and in renal
biopsies from lupus patients [13]. As discussed above there are
several ways in which DNA could become involved in glomer-
ular IC formation. There are reports that histone and nucleo-
some-like particles (DNA-histone complexes) may circulate in
patients with SLE [28—30]. The intact nucleosome core particle
itself has no affinity to the GBM when injected via the left renal
artery in rats (unpublished observation). This may be because
the cationic regions of the core histones are all covered with
anionic DNA. It is conceivable that when a part of DNA in the
nucleosome has been digested with DNase a cationic region
may be exposed and promote binding to GBM, as it has been
previously shown that even when the net overall charge of a
molecule is negative, possession of cationic regions can endow
it with affinity for the GBM [31]. This latter idea theoretically is
just as appealing as the concept presented here, it remains to be
shown which mechanism is involved in reality.
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